Based on the bioholographic theory, this study preliminarily explores the clinical efficacy of hand acupuncture in treating acute exacerbation of bronchial asthma and evaluates its immediate anti-asthmatic effect, so as to provide a new therapeutic strategy for the clinical management of bronchial asthma.
Patients meeting the Western medicine diagnostic criteria for acute exacerbation of bronchial asthma
Aged ≥ 18 years old
Voluntarily receive treatment and sign the informed consent form
Those who fail to meet the inclusion criteria
Patients suffering from other severe systemic diseases such as diseases of the circulatory system, hematological system and nervous system
Pregnant or lactating women
Subjects enrolled but not treated per the study protocol
Parallel
Acupuncture
Other interventionThe acupoints selected were Kechuan point, New Kechuan point, and Yuji point. The treatment was administered once a day for 20 minutes each time, for 5 consecutive days.
Standard Western medicine treatment
DrugEvaluate and manage in accordance with the Chinese Expert Consensus on Assessment and Management of Acute Exacerbation of Bronchial Asthma issued by the Asthma Group of the Chinese Thoracic Society, Chinese Medical Association in 2018 and the Guidelines for the Prevention and Treatment of Bronchial Asthma (2020 ).
Peak Expiratory Flow(PEF)
PEF will be used to assess pulmonary function
Asthma Control Test
The ACT score consists of 5 questions, each scored from 1 to 5 points, with a total score ranging from 5 to 25 points; lower scores indicate more severe symptoms.
Forced expiratory volume in first second/pred（FEV1%pred）
FEV1%pred will be used to assess pulmonary function
Clinical Symptom and Sign Score
It includes six symptoms: cough, expectoration, chest tightness, wheezing, shortness of breath and wheeze. Scores of 0, 3, 6 and 9 are assigned according to the severity of symptoms, with higher scores corresponding to more severe symptoms.
Mini Asthma Quality of Life Questionnaire（Mini-AQLQ)
It consists of 15 questions, each scored on a scale from 1 to 7 based on the severity of symptoms and their degree of impact. A score of 1 indicates no symptoms or no adverse impacts, while a score of 7 stands for severe symptoms or substantial impairment. Lower total scores correspond to a higher quality of life.
modified Medical Research Council (mMRC)
Scores range from 0 to 4 based on the severity of dyspnea, with higher scores indicating more severe symptoms.
Click on the lead sponsor to view all of their trials.
